LXRs, Cholesterol Metabolism and Uterine Dystocia
The Role of Two Nuclear Receptors for Oxysterols as a Molecular Cause of Uterine Dystocia: LXR Alpha and LXR Beta
Sponsor: Centre Hospitalier Universitaire de Nīmes
Terminated
Inclusion curve too slow.
Other terminated trials from Centre Hospitalier Universitaire de Nīmes
- Colorectal Cancer Metastatic · Phase NA · Oct 2025
- Deep Vein Thrombosis (DVT)/Thrombophlebitis · Feb 2025
- Atrial Fibrillation · Phase NA · Dec 2024
- Acute Kidney Injury · Phase PHASE3 · Dec 2024
- Rheumatoid Arthritis · Phase NA · Sep 2024
See all terminations from Centre Hospitalier Universitaire de Nīmes
Other Dystocia trials with similar outcome
Listed as NCT01107158, this observational or N/A phase trial focuses on Dystocia and Uterine Inertia and remains terminated or withdrawn. Sponsored by Centre Hospitalier Universitaire de Nīmes, it has been updated 11 times since 2010, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Dec 2025 — Present [monthly]
Terminated
-
Sep 2024 — Dec 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
▶ Show 6 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Jun 2018 — Nov 2020 [monthly]
Terminated
-
May 2018 — Jun 2018 [monthly]
Terminated
-
Apr 2018 — May 2018 [monthly]
Terminated
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Terminated NA
-
Jan 2017 — Aug 2017 [monthly]
Terminated NA
First recorded
Apr 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire de Nīmes
For direct contact, visit the study record on ClinicalTrials.gov .